These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6643711)

  • 61. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study.
    Kanner RE; Connett JE; Williams DE; Buist AS
    Am J Med; 1999 Apr; 106(4):410-6. PubMed ID: 10225243
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Early detection for lung cancer. New tools for casefinding.
    Lam S; Lam B; Petty TL
    Can Fam Physician; 2001 Mar; 47():537-44. PubMed ID: 11281087
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry.
    Di Marco F; Terraneo S; Job S; Rinaldo RF; Sferrazza Papa GF; Roggi MA; Santus P; Centanni S
    Respir Med; 2017 Jun; 127():7-13. PubMed ID: 28502420
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sensitivity and specificity of early diagnostic tests of lung function in smokers.
    Dosman JA; Cotton DJ; Graham BL; Hall DL; Li R; Froh F; Barnett GD
    Chest; 1981 Jan; 79(1):6-11. PubMed ID: 7449508
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Strategies for screening for chronic obstructive pulmonary disease.
    Enright PL; Kaminsky DA
    Respir Care; 2003 Dec; 48(12):1194-201; discussion 1201-3. PubMed ID: 14651760
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study.
    Van Schayck CP; Loozen JM; Wagena E; Akkermans RP; Wesseling GJ
    BMJ; 2002 Jun; 324(7350):1370. PubMed ID: 12052807
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pulmonary function test abnormalities in the elderly with systolic heart failure.
    Kurzawa R; Baron T; Grodzicki T
    Kardiol Pol; 2007 Aug; 65(8):875-80; discussion 881-2. PubMed ID: 17853316
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Economic issues in the use of office spirometry for lung health assessment.
    Krahn M; Chapman KR
    Can Respir J; 2003 Sep; 10(6):320-6. PubMed ID: 14530824
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of forced expiratory volume in one second (FEV1) among asymptomatic smokers and non-smokers.
    Khan A; Shabbir K; Ansari JK; Zia N
    J Pak Med Assoc; 2010 Mar; 60(3):209-13. PubMed ID: 20225780
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Measuring pulmonary function in practice.
    Gruffydd-Jones K
    Practitioner; 2002 Jun; 246(1635):445-9. PubMed ID: 12073703
    [No Abstract]   [Full Text] [Related]  

  • 71. Screening for and early detection of chronic obstructive pulmonary disease.
    Soriano JB; Zielinski J; Price D
    Lancet; 2009 Aug; 374(9691):721-32. PubMed ID: 19716965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Predictors of success in smoking cessation among participants of spirometric screening for COPD].
    Górecka D; Bednarek M; Nowiński A; Kamiński D; Bieleń P; Kołakowski J; Pływaczewski R; Goljan A; Puścińska E; Zieliński J
    Pneumonol Alergol Pol; 2001; 69(11-12):611-6. PubMed ID: 12134436
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pulmonary function testing in pediatric practice.
    Mueller GA; Eigen H
    Pediatr Rev; 1994 Oct; 15(10):403-11. PubMed ID: 7997445
    [No Abstract]   [Full Text] [Related]  

  • 74. [A test for early detection of COPD].
    Czajkowska-Malinowska M; Zieliński J
    Pneumonol Alergol Pol; 2000; 68(5-6):207-12. PubMed ID: 11004857
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Screening for chronic obstructive pulmonary disease by electronic mini-spirometry in general practice].
    Vorilhon P; Deat J; Gérard A; Laine E; Laporte C; Ruivard M; Vaillant Roussel H
    Rev Mal Respir; 2014 May; 31(5):396-403. PubMed ID: 24878155
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevalence of spirometric abnormalities in a representative sample of the population of Michigan.
    Miller A; Warshaw R; Thornton JC
    Am J Ind Med; 1991; 19(4):473-85. PubMed ID: 2035547
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacist-managed chronic obstructive pulmonary disease screening in a community setting.
    Fuller L; Conrad WF; Heaton PC; Panos R; Eschenbacher W; Frede SM
    J Am Pharm Assoc (2003); 2012; 52(5):e59-66. PubMed ID: 22975798
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Changing patterns in asbestos-induced lung disease.
    Ohar J; Sterling DA; Bleecker E; Donohue J
    Chest; 2004 Feb; 125(2):744-53. PubMed ID: 14769760
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.
    Lowry KP; Gazelle GS; Gilmore ME; Johanson C; Munshi V; Choi SE; Tramontano AC; Kong CY; McMahon PM
    Cancer; 2015 May; 121(10):1556-62. PubMed ID: 25652107
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [National Program of Early Detection and Prevention of COPD in the years 2000-2002].
    Zieliński J; Bednarek M; Górecka D;
    Pneumonol Alergol Pol; 2005; 73(2):116-21. PubMed ID: 16756139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.